Cite
HARVARD Citation
Ikezawa, K. et al. (2021). Efficacy and safety of modified fluorouracil/leucovorin plus irinotecan and oxaliplatin (mFOLFIRINOX) compared with S‐1 as second‐line chemotherapy in metastatic pancreatic cancer. JGH open. 5 (6), pp. 679-685. [Online].